Item 2.02 - Results of Operations and Financial Condition.
On January 9, 2020, SI-BONE, Inc. (the "Company") issued a press release (the
"Press Release") announcing preliminary unaudited revenue for the fourth quarter
and full year 2019 and providing full year 2020 revenue guidance. A copy of the
Press Release is attached as Exhibit 99.1 to this current report on Form 8-K and
is incorporated by reference herein.
Item 7.01 - Regulation FD Disclosure.
Members of the Company's management team expect to meet with investors and
analysts at the J.P. Morgan Annual Healthcare Conference on January 13, 2020 and
January 14, 2020 to discuss the Company, using presentation materials which are
furnished and attached as Exhibit 99.2.
The information in this Items 2.02 and 7.01 and Exhibits 99.1 and 99.2 of this
Current Report on Form 8-K are being furnished and shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934 as amended
(Exchange Act), or otherwise subject to the liabilities of that Section or
Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (Securities
Act). The information in Items 2.02 and 7.01 and Exhibits 99.1 and 99.2 shall
not be deemed incorporated by reference in any filing under the Securities Act,
or the Exchange Act, except as expressly set forth by specific reference in such
a filing.
Item 9.01 - Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated January 9, 2020
99.2 Presentation dated January 2020
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
SI-BONE, INC. 
